AAAAAA

   
Results: 1-10 |
Results: 10

Authors: JONG MC GIJBELS MJJ DAHLMANS VEH VANGORP PJJ KOOPMAN SJ PONEC M HOFKER MH HAVEKES LM
Citation: Mc. Jong et al., HYPERLIPIDEMIA AND CUTANEOUS ABNORMALITIES IN TRANSGENIC MICE OVEREXPRESSING HUMAN APOLIPOPROTEIN C1, The Journal of clinical investigation, 101(1), 1998, pp. 145-152

Authors: MOEN CJA VANGORP PJJ GIJBELS MJJ DEKRAKER J FRANTS RR HOFKER MH
Citation: Cja. Moen et al., TOWARDS IDENTIFICATION OF NEW GENES MODIFYING PLASMA-LIPID LEVELS ANDSUSCEPTIBILITY TO ATHEROSCLEROSIS, Circulation, 98(17), 1998, pp. 2797-2797

Authors: DEWINTHER MPJ GIJBELS MJJ VANDIJK KW VANGORP PJJ KODAMA T FRANTS RR HAVEKES LM HOFKER MH
Citation: Mpj. Dewinther et al., ATHEROSCLEROSIS IN SCAVENGER RECEPTOR-DEFICIENT APOE3LEIDEN TRANSGENIC MICE, Atherosclerosis, 134(1-2), 1997, pp. 33-33

Authors: JONG MC DAHLMANS VEH VANGORP PJJ VANDIJK KW HOFKER MH HAVEKES LM
Citation: Mc. Jong et al., THE BINDING OF VERY-LOW-DENSITY LIPOPROTEINS (VLDL) TO THE VLDL RECEPTOR IS INHIBITED BY APOLIPOPROTEIN (APO) C1, Atherosclerosis, 134(1-2), 1997, pp. 358-358

Authors: DEWINTHER MPJ GIJBELS MJJ VANDIJK KW VANGORP PJJ KODAMA T FRANTS RR HAVEKES LM HOFKER MH
Citation: Mpj. Dewinther et al., ENHANCED ATHEROSCLEROSIS IN MACROPHAGE SCAVENGER RECEPTOR-DEFICIENT APOE3LEIDEN TRANSGENIC MICE, Circulation, 96(8), 1997, pp. 2743-2743

Authors: JONG MC DAHLMANS VEH VANGORP PJJ BREUER ML MOL MJTM VANDERZEE A FRANTS RR HOFKER MH HAVEKES LM
Citation: Mc. Jong et al., BOTH LIPOLYSIS AND HEPATIC-UPTAKE OF VLDL ARE IMPAIRED IN TRANSGENIC MICE COEXPRESSING HUMAN APOLIPOPROTEIN E-ASTERISK-3LEIDEN AND HUMAN APOLIPOPROTEIN C1, Arteriosclerosis, thrombosis, and vascular biology, 16(8), 1996, pp. 934-940

Authors: JONG MC DAHLMANS VEH VANGORP PJJ VANDIJK KW BREUER ML HOFKER MH HAVEKES LM
Citation: Mc. Jong et al., IN THE ABSENCE OF THE LOW-DENSITY-LIPOPROTEIN RECEPTOR, HUMAN APOLIPOPROTEIN C1 OVEREXPRESSION IN TRANSGENIC MICE INHIBITS THE HEPATIC-UPTAKE OF VERY-LOW-DENSITY LIPOPROTEINS VIA A RECEPTOR-ASSOCIATED PROTEIN-SENSITIVE PATHWAY, The Journal of clinical investigation, 98(10), 1996, pp. 2259-2267

Authors: VANVLIJMEN BJM VANDIJK KW VANTHOF HB VANGORP PJJ VANDERZEE A VANDERBOOM H BREUER ML HOFKER MH HAVEKES LM
Citation: Bjm. Vanvlijmen et al., IN THE ABSENCE OF ENDOGENOUS MOUSE APOLIPOPROTEIN-E, APOLIPOPROTEIN E-ASTERISK-2(ARG-158-]CYS) TRANSGENIC MICE DEVELOP MORE SEVERE HYPERLIPOPROTEINEMIA THAN APOLIPOPROTEIN E-ASTERISK-3-LEIDEN TRANSGENIC MICE, The Journal of biological chemistry, 271(48), 1996, pp. 30595-30602

Authors: JONG MC DAHLMANS VEH VANGORP PJJ VANDIJK KW HOFKER MH HAVEKES LM
Citation: Mc. Jong et al., OVEREXPRESSION OF HUMAN APOC1 IN TRANSGENIC MICE INHIBITS THE HEPATIC-UPTAKE OF VLDL VIA A RECEPTOR-ASSOCIATED PROTEIN (RAP)-SENSITIVE PATHWAY, Circulation, 94(8), 1996, pp. 4077-4077

Authors: JONG MC DAHLMANS VEH VANGORP PJJ VANDIJK KW KOOPMAN SJ CHAN L HOFKER MH HAVEKES LM
Citation: Mc. Jong et al., THE BINDING OF VLDL TO THE VLDL RECEPTOR IS INHIBITED BY AN EXCESS OFAPOC1, Circulation, 94(8), 1996, pp. 4081-4081
Risultati: 1-10 |